The management of women classified as a pregnancy of unknown location (PUL) is often inconsistent. A variety of diagnostic protocols exist and are largely based on the serum markers hCG (human chorionic gonadotrophin) and progesterone. Other novel biomarkers (e.g. creatine kinase), ultrasound-based markers (e.g. endometrial thickness on ultrasound) and clinical markers (e.g. vaginal bleeding experienced) have also been assessed. This study presents the first meta-analysis and systematic review that summarises the evidence related to these management strategies. Methods: 43 studies qualified for inclusion in the study by searching MEDLINE, The Cochrane Library and DARE databases, as well as secondary referencing. The primary outcome was correct risk prediction. In the context of PUL, this is either high-risk: final outcome of an ectopic pregnancy (EP) or low-risk: final outcome of failed PUL (FPUL) or intrauterine pregnancy (IUP, either viable or non-viable). QUADAS-2 criteria were used to assess the risk of bias. A hierarchical summary receiver operating curve (HSROC) model was fitted to account for the variation in cut-offs. Results: There were enough studies to perform a meta-analysis of diagnostic accuracy on (i) single hCG, (ii) the hCG ratio (hCG at 48 hours/ initial hCG), (iii) single progesterone and (iv) the M4 model (a logistic regression model based on the initial hCG and hCG ratio). Conclusions: The M4 model had the best overall test performance in determining final outcome. Focusing on the development of logistic regression models may be the best way forward in rationalising the management of PUL.
OP11.07
The natural history of pregnancy-related enhanced myometrial vascularity (EMV) K. Grewal, M. Al-Memar, H. Fourie, V. Djapardy, T. Bourne Charlotte's and Chelsea Hospital, Imperial College London, London, United Kingdom Objectives: Enhanced myometrial vascularity is a term used to describe a rich vascular network with high velocity flow. We aimed to evaluate the outcomes of pregnancy related EMV. Methods: A prospective audit of practice in a London teaching hospital between October 2015 to March 2017. Inclusion criteria was the diagnosis of pregnancy related EMV by transvaginal ultrasonography (US). This involved subjective identification of increased myometrial vascularity and a PSV greater than 20cm/sec within the collection of vessels. Clinical outcomes and ultrasound findings were collected. Resolution was defined as the date of surgery or when products of conception were no longer visible, in those cases managed expectantly. Results: 29 patients were diagnosed with EMV. All cases were associated with retained products of conception post pregnancy (28/29 post miscarriage; 1/29 postpartum). 19 patients initially opted for expectant management, of which 12 were successful and 7 required later surgical evacuation. 8 patients chose to have surgical evacuation in the first instance and only one patient clinically required surgical evacuation. There was no correlation between PSV and blood loss at surgery (PSV ranges 20-83). For those that had expectant management, vascularity took longer to resolve compared with surgery (57 days with range, 21-140 compared to 19 days with range, 1-53 respectively). One patient expectantly managed required a blood transfusion. Conclusions: Although a small cohort, this is the largest prospective case series in the current literature. The findings suggest that despite EMV, bleeding was often minimal with surgical evacuation and no cases required hysterectomy or embolisation. These findings suggest both expectant and surgical management are appropriate. However, the expectant approach takes longer to resolve. EMV itself may be an iatrogenic ultrasound diagnosis that is associated with the natural history of miscarriage which resolves with time.
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The management of recurrent ectopic pregnancy: a multicentre observational study Objectives: Women with a previous ectopic pregnancy (EP) have a 10 fold increased risk of a subsequent EP. It is intuitive that previous surgical treatment would favour tubal sparing management in a subsequent EP. There is, however, limited published data on whether having had a previous ectopic significantly impacts the decision for management of a subsequent EP.
Methods:
This was a secondary analysis of prospectively collected data on all tubal EP diagnosed from January 2011 -August 2016 at two teaching hospitals. All patients had a transvaginal ultrasound scan and serum hCG and progesterone measurements. Treatment included expectant, medical (Methotrexate) or surgical management (laparoscopic salpingectomy or salpingostomy). All EP were followed up until the hCG level was <15IU/L or they had a negative urinary pregnancy test. Analysis was performed using GraphPad Prism V7. Results: Of 560 tubal EP, there was complete outcome data for 545 patients. 84/545 (15%) had had a previous EP. In the 461 women with a first-time EP, the selected management was medical in 78/461 (17%), surgical in 242/461 (52%) and expectant in 141/461 (31%) cases. In the 84 women with a previous EP, their current EP was managed medically in 21/84 (25%), surgically in 40/84 (48%) and expectantly in 23/84 cases (27%). There was no statistical difference between the two groups (p=0.22, Fisher exact test). For their previous EP, 8/84 (10%) were managed medically, 59/84 (70%) surgically and 17/84 (20%) expectantly. There was a statistically significant difference between current and previous management of EP (p=0.006, Fisher exact test). Conclusions: In this cohort, there was a significant difference between the management of a first and subsequent EP. Further prospective studies will determine whether this is because women and their clinicians are more likely to opt for tubal-sparing treatment when there is recurrence of an EP.
